FOLH1 and neoplasm: However, the mere number of new lesions is not explicitly assessable in the light of the extensive tumor load in most end-stage patients undergoing RLT due to the occurrence of vast confluent bone sclerosis and partially coalescing, PSMA-avid tumor lesions.